Emergent Biosolutions Sells Baltimore Facility for $30 Million
- Emergent Biosolutions has sold its Baltimore facility to Bora for $30 million.
- This sale marks a significant shift in Emergent's business strategy, as it moves away from its contract development and manufacturing organization (CDMO) business.